ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.

@article{Tsai2010ENO1AP,
  title={ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.},
  author={S W Tsai and I-Hsiu Chien and Wen-hao Shen and Yi-Zih Kuo and Ying-tai Jin and Tung-Yiu Wong and J R Hsiao and Hsing-Ping Wang and N Shih and Li-Wha Wu},
  journal={European journal of cancer},
  year={2010},
  volume={46 9},
  pages={
          1712-23
        }
}
The success of using glycolytic inhibitors for cancer treatment depends on studying the individual role of frequently deregulated glycolytic genes in cancer. This report aims to study the prognostic implication, and determine the cellular role and action mechanism of glycolytic ENO1 overexpression in head and neck cancer. The relationship of ENO1 mRNA expression in 44-pair clinical specimens with patient clinicopathologic characteristics was analysed by semi-quantitative RT-PCR, Kaplan-Meier… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 42 CITATIONS

Alpha-enolase promotes gastric cancer cell proliferation and metastasis via regulating AKT signaling pathway.

  • European journal of pharmacology
  • 2019
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

A bFGF Antagonist Peptide with Anti-angiogenesis Properties in Non-small Cell Lung Cancer Cells

  • International Journal of Peptide Research and Therapeutics
  • 2013
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED